Patent application number | Description | Published |
20090036421 | Pyrrole Derivative or Salt Thereof - [Problem] To provide a compound which may be used for the prevention and/or treatment of diseases in which 5-HT | 02-05-2009 |
20090062363 | AMIDE DERIVATIVE OR SALT THEREOF - [Problem] To provide a compound which can be used for the prevention and/or treatment of diseases in which 5-HT | 03-05-2009 |
20090062366 | Pyrrolidine derivative or salt thereof - [Problem] To provide a compound which may be used in treating diseases in which a calcium sensing receptor (CaSR) is concerned, particularly hyperparathyroidism. | 03-05-2009 |
20100029687 | PIPERIDINE DERIVATIVE OR SALT THEREOF - [Problem] To provide a compound which can be used for treating diseases in which a calcium sensing receptor (CaSR) participates, particularly hyperparathyroidism. | 02-04-2010 |
20100216803 | ORNITHINE DERIVATIVE - Provided is a compound which is useful as a therapeutic agent for chronic renal insufficiency and a therapeutic agent for diabetic nephropathy. | 08-26-2010 |
20100249088 | AZOLECARBOXAMIDE COMPOUND OR SALT THEREOF - [Object] To provide a therapeutic and/or prophylactic agent for urinary frequency, urinary urgency, and urinary incontinence associated with various lower urinary tract diseases including overactive bladder, various lower urinary tract diseases accompanied by lower urinary tract pain, such as interstitial cystitis, chronic prostatitis, and the like, and various diseases accompanied by pain, based on an excellent trkA receptor inhibitory action. | 09-30-2010 |
20110028463 | AMIDE COMPOUNDS - [Problems] To provide a compound that is useful as an agent for treating chronic renal insufficiency or an agent for treating diabetic nephropathy.
| 02-03-2011 |
20110144153 | AMIDE COMPOUND - [Problems] A compound, which is useful as an active ingredient of a pharmaceutical composition, for example, a pharmaceutical composition for treating chronic renal failure and/or diabetic nephropathy, is provided. | 06-16-2011 |
20110319385 | QUINOXALINE COMPOUND | 12-29-2011 |
20120184521 | SUBSTITUTED AMIDE COMPOUND - A substituted amide compound is useful as an active ingredient of a pharmaceutical composition, in particular a pharmaceutical composition for treating diseases caused by lysophosphatidic acid (LPA). The compound is of a formula: | 07-19-2012 |
20130085134 | QUINOXALINE COMPOUND - Quinoxaline compounds of formula (I) have a PDE9-inhibiting action and are useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like. | 04-04-2013 |
20130225553 | PYRAZOLOQUINOLINE COMPOUND - The present inventors have investigated a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, bladder/urethral diseases, and the like, and thus, have found that a pyrazoloquinoline compound has a PDE9-inhibiting action, thereby completing the present invention. | 08-29-2013 |
20130231320 | SUBSTITUTED AMIDE COMPOUND - A substituted amide compound is useful as an active ingredient of a pharmaceutical composition, in particular a pharmaceutical composition for treating diseases caused by lysophosphatidic acid (LPA). The compound is of a formula: | 09-05-2013 |
20130296329 | QUINOXALINE COMPOUND - The present inventors have investigated a compound which has a PDE9-inhibitory action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like, and thus, have found that an imidazoquinoxaline compound or a triazoloquinoxaline compound has a PDE9-inhibitory action, thereby completing the present invention. | 11-07-2013 |